Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Cleary

Showing results (321-330 of 334) with videos related to

Pageof 34
Sort By:
Medrxiv : the Preprint Server for Health Sciences|April 1, 2025
Depression Risk and Work Hours in Training Physicians Before and During the COVID-19 PandemicJennifer L Cleary, Karina Pereira-Lima, Xianda Ma, et al.
Cancer Discovery|May 8, 2016
ASH1L Links Histone H3 Lysine 36 Dimethylation to MLL LeukemiaLi Zhu, Qin Li, Stephen H K Wong, et al.
Cancer Research|September 29, 2018
CBP Modulates Sensitivity to Dasatinib in Pre-BCR<sup>+</sup> Acute Lymphoblastic LeukemiaJesús Duque-Afonso, Chiou-Hong Lin, Kyuho Han, et al.
Brain, Behavior, and Immunity|March 19, 2024
A single bout of vigorous intensity exercise enhances the efficacy of rituximab against human chronic lymphocytic leukaemia B-cells ex vivoHarrison D Collier-Bain, Annabelle Emery, Adam J Causer, et al.
The American Journal of Surgical Pathology|January 29, 2008
A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumorsInigo Espinosa, Cheng-Han Lee, Mi Kyung Kim, et al.
Genome Research|April 1, 2011
MicroRNA programs in normal and aberrant stem and progenitor cellsChristopher P Arnold, Ruoying Tan, Baiyu Zhou, et al.
Cancer Cell|July 12, 2011
Cell of origin in AML: susceptibility to MN1-induced transformation is regulated by the MEIS1/AbdB-like HOX protein complexMichael Heuser, Haiyang Yun, Tobias Berg, et al.
Blood Advances|April 10, 2024
Development of combination therapies with BTK inhibitors and dasatinib to treat CNS-infiltrating E2A-PBX1+/preBCR+ ALLGaia Gentile, Teresa Poggio, Antonella Catalano, et al.
Nature Communications|March 5, 2025
Structure-function relationship of ASH1L and histone H3K36 and H3K4 methylationKendra R Vann, Rajal Sharma, Chih-Chao Hsu, et al.
American Journal of Obstetrics and Gynecology|August 12, 2020
Prospective, randomized, double-blind, placebo-controlled evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm PreeclampsiaMichael J Paidas, Allan T N Tita, George A Macones, et al.
Pageof 34

Showing results (321-330 of 334) with videos related to

Sort By:
Pageof 34
Medrxiv : the Preprint Server for Health Sciences|April 1, 2025
Depression Risk and Work Hours in Training Physicians Before and During the COVID-19 PandemicJennifer L Cleary, Karina Pereira-Lima, Xianda Ma, et al.
Cancer Discovery|May 8, 2016
ASH1L Links Histone H3 Lysine 36 Dimethylation to MLL LeukemiaLi Zhu, Qin Li, Stephen H K Wong, et al.
Cancer Research|September 29, 2018
CBP Modulates Sensitivity to Dasatinib in Pre-BCR<sup>+</sup> Acute Lymphoblastic LeukemiaJesús Duque-Afonso, Chiou-Hong Lin, Kyuho Han, et al.
Brain, Behavior, and Immunity|March 19, 2024
A single bout of vigorous intensity exercise enhances the efficacy of rituximab against human chronic lymphocytic leukaemia B-cells ex vivoHarrison D Collier-Bain, Annabelle Emery, Adam J Causer, et al.
The American Journal of Surgical Pathology|January 29, 2008
A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumorsInigo Espinosa, Cheng-Han Lee, Mi Kyung Kim, et al.
Genome Research|April 1, 2011
MicroRNA programs in normal and aberrant stem and progenitor cellsChristopher P Arnold, Ruoying Tan, Baiyu Zhou, et al.
Cancer Cell|July 12, 2011
Cell of origin in AML: susceptibility to MN1-induced transformation is regulated by the MEIS1/AbdB-like HOX protein complexMichael Heuser, Haiyang Yun, Tobias Berg, et al.
Blood Advances|April 10, 2024
Development of combination therapies with BTK inhibitors and dasatinib to treat CNS-infiltrating E2A-PBX1+/preBCR+ ALLGaia Gentile, Teresa Poggio, Antonella Catalano, et al.
Nature Communications|March 5, 2025
Structure-function relationship of ASH1L and histone H3K36 and H3K4 methylationKendra R Vann, Rajal Sharma, Chih-Chao Hsu, et al.
American Journal of Obstetrics and Gynecology|August 12, 2020
Prospective, randomized, double-blind, placebo-controlled evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm PreeclampsiaMichael J Paidas, Allan T N Tita, George A Macones, et al.
Pageof 34